Novartis profits plunge after US corruption case

Novartis profits plunge after US corruption case

Basel-based pharmaceutical giant Novartis said on Tuesday that its third-quarter net profit fell by 42 percent to $1.8 billion, partially due to provisions to settle a US corruption case.

US seeks $3.3 billion for Novartis ‘kickbacks’

US seeks $3.3 billion for Novartis ‘kickbacks’

Biogen announces billion-franc drugs plant

Biogen announces billion-franc drugs plant

Japan orders Novartis unit to suspend activities

Japan orders Novartis unit to suspend activities

Novartis faces Japan penalty over drug effects

Novartis faces Japan penalty over drug effects

placeholder image

Novartis notches higher profit on strong sales

Watchdog clears Novartis in flu jab scare

Watchdog clears Novartis in flu jab scare

Italy examines 13 deaths in Novartis flu jab probe

Italy examines 13 deaths in Novartis flu jab probe

Italy suspends Novartis vaccine after three die

Italy suspends Novartis vaccine after three die

New products push up Novartis Q3 earnings

New products push up Novartis Q3 earnings

Japan Novartis unit failed to report ‘drug deaths’

Japan Novartis unit failed to report ‘drug deaths’

Novartis heart drug billed ‘blockbuster’ after tests

Novartis heart drug billed ‘blockbuster’ after tests

Novartis reports sharply higher half-year profits

Novartis reports sharply higher half-year profits

Japan charges Novartis unit over falsified data

Japan charges Novartis unit over falsified data

Japan nabs ex-Novartis worker for ‘false data’

Japan nabs ex-Novartis worker for ‘false data’

Unit sale drives rise in Novartis Q1 net profits

Unit sale drives rise in Novartis Q1 net profits

Italy slaps Swiss pharma giants with huge fines

Italy slaps Swiss pharma giants with huge fines

Japanese raid Novartis offices in criminal probe

Japanese raid Novartis offices in criminal probe

Novartis plans to trim executive pay: report

Novartis plans to trim executive pay: report

Exchange rates cut Novartis profits for 2013

Exchange rates cut Novartis profits for 2013

Novartis lops 500 jobs in Basel restructuring

Novartis lops 500 jobs in Basel restructuring

Novartis ads in Japan draw criminal complaint

Novartis ads in Japan draw criminal complaint

Japan to file criminal action against Novartis

Japan to file criminal action against Novartis

Japan pursues Novartis unit over ‘fake’ drug data

Japan pursues Novartis unit over ‘fake’ drug data

Novartis sells blood unit to Spanish firm Grifols

Novartis sells blood unit to Spanish firm Grifols

‘Challenged’ Novartis looks to cut 440 UK jobs

‘Challenged’ Novartis looks to cut 440 UK jobs

Novartis shares jump on improved outlook

Novartis shares jump on improved outlook

Japan to raid Novartis over ‘fake data’: reports

Japan to raid Novartis over ‘fake data’: reports

Ex-Novartis chief defends planned payout

Ex-Novartis chief defends planned payout

Former Novartis chief stays on company payroll

Former Novartis chief stays on company payroll

Novartis under fire over false Japanese drug data

Novartis under fire over false Japanese drug data

Novartis expands Swiss plant eyed for closure

Novartis expands Swiss plant eyed for closure

Novartis ‘ready for new bird flu vaccine’

Novartis ‘ready for new bird flu vaccine’

Indian minister defends Novartis drug ruling

Indian minister defends Novartis drug ruling

Novartis drug ‘too costly’, UK officials say

Novartis drug ‘too costly’, UK officials say

Roche boosts dividend on higher profits

Roche boosts dividend on higher profits

Novartis chairman to step down as profits rise

Novartis chairman to step down as profits rise

Pharma firm cuts 400 Swiss jobs

Pharma firm cuts 400 Swiss jobs